Literature DB >> 9346586

Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation.

T Piratvisuth1, J M Tredger, K A Hayllar, R Williams.   

Abstract

The role of true cold ischemia times (CIT) and rewarming ischemia times (WIT) in determining outcome after liver transplantation was investigated in 230 adult recipients. Using multivariate analysis, WIT (time from the start of implantation until restoration of arterial and portal blood supply) and donor intensive care stay (P = .04 and .0004, respectively) but not CIT (the time from donor portal vein flushing until the graft was removed from University of Wisconsin solution; P > .30) emerged as independent determinants of graft survival. In the small number of patients with a WIT of greater than 180 minutes, there were reductions in graft survival (58% v 80% for WIT greater than 180 minutes) but these just failed to reach significance (P = .055). CIT had no influence on graft survival using cut-offs of 12 or 18 hours. A WIT of greater than 180 minutes was associated with an increased median area under the curve of day 1 through 7 serum bilirubin (1,370 v 915 mumol/L.day; P = .048) and trends towards an increased incidence of primary graft nonfunction or dysfunction (22.2% v 6.2% for WIT of less than 180 minutes; P = .065) and the day 1 through 7 area under the curve of serum aspartate aminotransferase (3,310 v 1,440 IU/L.day; P = .092). A prolonged CIT (greater than 18 hours) led to a prolonged hospital stay (69 v 31 days; P = .03), an increased area under the curve of day 8 through 14 serum bilirubin (2,500 v 995 mumol/L.day; P = .003), and a trend towards an increased incidence of initial poor graft function (33.3% v 6.3% for less than 18 hours; P = .092). The incidence of acute rejection increased (to 64.3% from 53.4%; P = .04) in patients with preservation injury (serum aspartate aminotransferase greater than 1,500 IU/L during the first 2 postoperative days). True CIT and WIT are important determinants of outcome after liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9346586     DOI: 10.1002/lt.500010505

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  11 in total

1.  Persufflation (or gaseous oxygen perfusion) as a method of organ preservation.

Authors:  Thomas M Suszynski; Michael D Rizzari; William E Scott; Linda A Tempelman; Michael J Taylor; Klearchos K Papas
Journal:  Cryobiology       Date:  2012-01-26       Impact factor: 2.487

Review 2.  Strategies to optimize the use of marginal donors in liver transplantation.

Authors:  Daniele Pezzati; Davide Ghinolfi; Paolo De Simone; Emanuele Balzano; Franco Filipponi
Journal:  World J Hepatol       Date:  2015-11-18

Review 3.  Using old liver grafts for liver transplantation: where are the limits?

Authors:  Carlos Jiménez-Romero; Oscar Caso Maestro; Félix Cambra Molero; Iago Justo Alonso; Cristina Alegre Torrado; Alejandro Manrique Municio; Jorge Calvo Pulido; Carmelo Loinaz Segurola; Enrique Moreno González
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 4.  Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature.

Authors:  Dronacharya Routh; Sudeep Naidu; Sanjay Sharma; Priya Ranjan; Rajesh Godara
Journal:  J Clin Exp Hepatol       Date:  2013-12-05

5.  Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years.

Authors:  Carlos Jiménez-Romero; Marta Clemares-Lama; Alejandro Manrique-Municio; Alvaro García-Sesma; Jorge Calvo-Pulido; Enrique Moreno-González
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

6.  Moving toward the utilization of all donated liver grafts. The "b-list" concept.

Authors:  D Vrochides; P Metrakos
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

7.  Effect of Donor Hepatic Steatosis on Ischemia Reperfusion Injury in Liver Transplant Recipient.

Authors:  Prafulla V Jadhav; Sunil Raviraj Kothakota; Madhu Sasidharan; Harish Kareem; Ajith K Nair
Journal:  J Clin Exp Hepatol       Date:  2019-07-12

8.  Oxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion.

Authors:  Anding Liu; Haoshu Fang; Olaf Dirsch; Hao Jin; Uta Dahmen
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

9.  Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation.

Authors:  Raffaele Cursio; Jean Gugenheim
Journal:  J Transplant       Date:  2012-02-29

10.  Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis.

Authors:  James E Stahl; Jennifer E Kreke; Fawaz Ali Abdul Malek; Andrew J Schaefer; Joseph Vacanti
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.